Overview
Lodewijk Ijlst practices practicing medicine in Amsterdam, Netherlands.
Ijlst is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, Rhabdomyolysis, Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome), and Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome).
They are actively involved in clinical research, co-authoring 41 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Lodewijk Ijlst
Is Lodewijk Ijlst a top-rated expert for Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency?
MediFind is an objective health platform that identifies experts based on real-world data. Lodewijk Ijlst is classified as an Distinguished expert for Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Lodewijk Ijlst participate in research or clinical trials?
Yes. Lodewijk Ijlst has published 41 articles and abstracts on conditions like Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency. You can view a list of Lodewijk Ijlst's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency
- Advanced
- Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)
- Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome)
- RhabdomyolysisIjlst isAdvanced. Learn about Rhabdomyolysis.
- Experienced
- Barth SyndromeIjlst isExperienced. Learn about Barth Syndrome.
- Carbamoyl Phosphate Synthetase 1 Deficiency
- Hereditary Spastic Paraparesis
- Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
- Mitochondrial Trifunctional Protein Deficiency
- Mucopolysaccharidoses (MPS)Ijlst isExperienced. Learn about Mucopolysaccharidoses (MPS).
- Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A)
- N-Acetylglutamate Synthase Deficiency
- Newborn Low Blood SugarIjlst isExperienced. Learn about Newborn Low Blood Sugar.
- Primary Carnitine DeficiencyIjlst isExperienced. Learn about Primary Carnitine Deficiency.
- Protein DeficiencyIjlst isExperienced. Learn about Protein Deficiency.
- Spastic Paraplegia Type 2Ijlst isExperienced. Learn about Spastic Paraplegia Type 2.
- Urea Cycle Disorders (UCD)Ijlst isExperienced. Learn about Urea Cycle Disorders (UCD).